These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 23810254)

  • 1. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model.
    Weber B; Dijkman PE; Scherman J; Sanders B; Emmert MY; Grünenfelder J; Verbeek R; Bracher M; Black M; Franz T; Kortsmit J; Modregger P; Peter S; Stampanoni M; Robert J; Kehl D; van Doeselaar M; Schweiger M; Brokopp CE; Wälchli T; Falk V; Zilla P; Driessen-Mol A; Baaijens FP; Hoerstrup SP
    Biomaterials; 2013 Oct; 34(30):7269-80. PubMed ID: 23810254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts.
    Dijkman PE; Driessen-Mol A; Frese L; Hoerstrup SP; Baaijens FP
    Biomaterials; 2012 Jun; 33(18):4545-54. PubMed ID: 22465337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates.
    Weber B; Scherman J; Emmert MY; Gruenenfelder J; Verbeek R; Bracher M; Black M; Kortsmit J; Franz T; Schoenauer R; Baumgartner L; Brokopp C; Agarkova I; Wolint P; Zund G; Falk V; Zilla P; Hoerstrup SP
    Eur Heart J; 2011 Nov; 32(22):2830-40. PubMed ID: 21415068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter implantation of homologous "off-the-shelf" tissue-engineered heart valves with self-repair capacity: long-term functionality and rapid in vivo remodeling in sheep.
    Driessen-Mol A; Emmert MY; Dijkman PE; Frese L; Sanders B; Weber B; Cesarovic N; Sidler M; Leenders J; Jenni R; Grünenfelder J; Falk V; Baaijens FPT; Hoerstrup SP
    J Am Coll Cardiol; 2014 Apr; 63(13):1320-1329. PubMed ID: 24361320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
    Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
    Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living autologous heart valves engineered from human prenatally harvested progenitors.
    Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
    Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis.
    Hof A; Raschke S; Baier K; Nehrenheim L; Selig JI; Schomaker M; Lichtenberg A; Meyer H; Akhyari P
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):446-55. PubMed ID: 27084195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
    Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
    Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.
    Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G
    Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves.
    Dijkman PE; Driessen-Mol A; de Heer LM; Kluin J; van Herwerden LA; Odermatt B; Baaijens FP; Hoerstrup SP
    J Heart Valve Dis; 2012 Sep; 21(5):670-8. PubMed ID: 23167234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Geometry of Decellularized Tissue Engineered Heart Valves to Prevent Leaflet Retraction.
    Sanders B; Loerakker S; Fioretta ES; Bax DJ; Driessen-Mol A; Hoerstrup SP; Baaijens FP
    Ann Biomed Eng; 2016 Apr; 44(4):1061-71. PubMed ID: 26183964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
    Leyh R; Wilhelmi M; Haverich A; Mertsching H
    Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
    Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
    Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions.
    Lichtenberg A; Tudorache I; Cebotari S; Suprunov M; Tudorache G; Goerler H; Park JK; Hilfiker-Kleiner D; Ringes-Lichtenberg S; Karck M; Brandes G; Hilfiker A; Haverich A
    Circulation; 2006 Jul; 114(1 Suppl):I559-65. PubMed ID: 16820637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.